Definitive Healthcare Q3 revenue beats at $62.7M; CFO Booth to depart June 2025; $100M buyback authorized

Definitive Healthcare Corp.

2024-Q3 EPS reported -$3.02 revenue$189,914,000

Q3 revenue $62.7M, down 4% YoY; net loss $(187.8)M includes $228.2M goodwill impairment; adjusted EBITDA $20.6M (33% margin).
CFO Richard Booth to leave effective June 1, 2025; granted 92,379 RSUs as retention incentive; search for successor underway.
Board authorized $100M stock repurchase program expiring Dec 31, 2025; replaces prior $20M program; no repurchases yet.
Entered voting agreement with Advent International to limit excess voting shares above 40.3% proportionally.
Guidance: Q4 revenue $60-61M, adjusted EBITDA $16-17M; full-year revenue $250-251M, adjusted EBITDA $77.5-78.5M.

item 2.02 item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Richard Booth

Chief Financial Officer

DH · Definitive Healthcare Corp.

Effective: 2025-06-01
Filed: November 7, 2024, 6:59 PM ET

Richard Booth, the Company’s Chief Financial Officer, and the Company agreed that Mr. Booth will be leaving the Company effective June 1, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Booth departed as Chief Financial Officer at Definitive Healthcare Corp..

Action: agreed to leave
Role: Chief Financial Officer

Exact text from the filing

Richard Booth, the Company’s Chief Financial Officer, and the Company agreed that Mr. Booth will be leaving the Company effective June 1, 2025.

View on SEC.gov

Definitive Healthcare Corp. filing history →

Source: SEC EDGAR

accession 0000950170-24-123356

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.